Display options
Cite
Ichikawa S, Ichikawa T, Motosugi U, et al. Was Hypervascular Hepatocellular Carcinoma Visible on Previous Gadoxetic Acid-Enhanced Magnetic Resonance Images?. Liver Cancer. 2015;4(3):154-62doi: 10.1159/000367736.
Ichikawa, S., Ichikawa, T., Motosugi, U., Sano, K., Morisaka, H., Enomoto, N., Matsuda, M., & Fujii, H. (2015). Was Hypervascular Hepatocellular Carcinoma Visible on Previous Gadoxetic Acid-Enhanced Magnetic Resonance Images?. Liver cancer, 4(3), 154-62. https://doi.org/10.1159/000367736
Ichikawa, Shintaro, et al. "Was Hypervascular Hepatocellular Carcinoma Visible on Previous Gadoxetic Acid-Enhanced Magnetic Resonance Images?." Liver cancer vol. 4,3 (2015): 154-62. doi: https://doi.org/10.1159/000367736
Ichikawa S, Ichikawa T, Motosugi U, Sano K, Morisaka H, Enomoto N, Matsuda M, Fujii H. Was Hypervascular Hepatocellular Carcinoma Visible on Previous Gadoxetic Acid-Enhanced Magnetic Resonance Images?. Liver Cancer. 2015 Sep;4(3):154-62. doi: 10.1159/000367736. Epub 2015 Jun 05. PMID: 26674263; PMCID: PMC4608601.
Copy Download .nbib Format: NLM
Share it on

Liver Cancer. 2015 Sep;4(3):154-62. doi: 10.1159/000367736. Epub 2015 Jun 05.

Was Hypervascular Hepatocellular Carcinoma Visible on Previous Gadoxetic Acid-Enhanced Magnetic Resonance Images?.

Liver cancer

Shintaro Ichikawa, Tomoaki Ichikawa, Utaroh Motosugi, Katsuhiro Sano, Hiroyuki Morisaka, Nobuyuki Enomoto, Masanori Matsuda, Hideki Fujii

Affiliations

  1. Department of Radiology, Yamanashi, Japan.
  2. First Department of Internal Medicine, Yamanashi, Japan.
  3. First Department of Surgery, University of Yamanashi, Yamanashi, Japan.

PMID: 26674263 PMCID: PMC4608601 DOI: 10.1159/000367736

Abstract

BACKGROUND: During the follow-up of patients with chronic liver disease, hypervascular hepatocellular carcinomas (HCCs) can develop either from pre-existing high-risk nodules or by de novo hepatocarcinogenesis. The purpose of this study was to evaluate, by retrospective analysis, the detectability and signal intensity on previous hepatocyte-phase gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging (EOB-MRI) of hypervascular HCC initially detected on current EOB-MRIs.

METHODS: We examined 50 initially detected hypervascular HCCs that showed typical enhancement features on EOB-MRI in 39 patients whose previous EOB-MRI images obtained 6-19 months earlier were available. The detectability of each hypervascular HCC on the hepatocyte phase images of previous EOB-MRIs was assessed. The imaging features on hepatocyte-phase images of previous EOB-MRIs at the locations where hypervascular HCCs were found on the current EOB-MRI images were classified as detectable or undetectable. The signal intensities of detectable nodules (defined as group A) on hepatocyte-phase images of previous EOB-MRIs were classified as hypo-, iso-, or hyperintensity. Nodules undetectable on the hepatocyte-phase images of previous EOB-MRIs were assigned to group B.

RESULTS: Twenty-two (22/50, 44%) hypervascular HCCs were detectable on the earlier hepatocyte phase images (group A). In contrast, 28 (28/50, 56%) hypervascular HCCs were not detectable on the hepatocyte phase of earlier EOB-MRI images (group B).

CONCLUSION: When the previous EOB-MRI images were used as the reference, more than half (28/50, 56%) of hypervascular HCCs initially appearing on the current EOB-MRI images were found not to have developed from nodules detectable on the previous MRIs through the traditionally accepted process of multistep carcinogenesis. Instead, they seemed to have developed via an "imaging-occult" process of carcinogenesis in patients with chronic liver diseases.

Keywords: Carcinogenesis; Gadoxetic acid; Hepatocellular carcinoma; Magnetic resonance imaging (MRI)

References

  1. Hepatology. 2011 Mar;53(3):1020-2 - PubMed
  2. Liver Transpl. 2009 Nov;15(11):1412-6 - PubMed
  3. Radiology. 2010 Jul;256(1):151-8 - PubMed
  4. J Magn Reson Imaging. 2012 Feb;35(2):393-8 - PubMed
  5. Radiology. 2004 Jan;230(1):266-75 - PubMed
  6. Acta Radiol. 2006 Feb;47(1):15-23 - PubMed
  7. Eur J Radiol. 2012 Nov;81(11):3072-8 - PubMed
  8. Korean J Radiol. 2011 Jul-Aug;12(4):403-15 - PubMed
  9. Liver Transpl. 2008 Feb;14(2):228-34 - PubMed
  10. Radiology. 2012 Oct;265(1):104-14 - PubMed
  11. Am J Gastroenterol. 1998 Dec;93(12):2588-93 - PubMed
  12. Radiographics. 2009 Oct;29(6):1637-52 - PubMed
  13. Radiology. 2011 Dec;261(3):834-44 - PubMed
  14. Radiology. 2013 Feb;266(2):480-90 - PubMed
  15. J Magn Reson Imaging. 2011 Jul;34(1):88-94 - PubMed
  16. Hum Pathol. 1991 Feb;22(2):172-8 - PubMed
  17. AJR Am J Roentgenol. 2011 Jul;197(1):58-63 - PubMed
  18. Magn Reson Imaging Clin N Am. 2002 Feb;10(1):31-52, v - PubMed

Publication Types